Table 2.
Phenotype | Shared TCRα/TCRβ sequences | Presence and reactivity a) | b) Previously reported dataset of public gluten‐specific TCRs; c) number of CeD patients | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CD2126 | CD2135 | CD2219 | CD2326 | CD5028 | CD5030 | CD5037 | CD5038 | CD5058 | CD5060 | CD5063 | CD5065 | |||
Ttet+/Tphe+ | AV4_LVGGSGGYNKLI_AJ4 | R2 | O, [ 25 ]; 13 | |||||||||||
AV41_AVEGGSNYKLT_AJ53 | O, [ 25 ]; 10 | |||||||||||||
BV7‐2_ASSIRATDTQY_BJ2‐3 | R1 | O, [ 25 ]; 9 | ||||||||||||
BV7‐3_ASSIRSTDTQY_BJ2‐3 | NR1 | O, [ 25 ]; 14 | ||||||||||||
BV20‐1_SASRTSGRAGDEQF_BJ2‐1 | O, [ 26 ]; 6 | |||||||||||||
Ttet−/Tphe+ | AV9‐2_ALSDQGSSASKII_AJ3* | NO | ||||||||||||
AV9‐2_ALSDPTGTASKLT_AJ44 | O, [ 25 ]; 4 | |||||||||||||
AV10_VVSGGYYGGSQGNLI_AJ42 | NO | |||||||||||||
AV12‐1_VVNPGGGNKLT_AJ10 | NR1 | NO | ||||||||||||
AV20_AVPNAGGTSYGKLT_AJ52 | NR1 | NO | ||||||||||||
AV22_AVEREGAQKLV_AJ54 | R3 | NO | ||||||||||||
AV36_AVGQGAQKLV_AJ54 | NO | |||||||||||||
AV38‐2_AYRSEQGAQKLV_AJ54 | NO | |||||||||||||
BV7‐3_ASSQGQDTEAF_BJ1‐1 | R1 | O, [ 25 ]; 5 | ||||||||||||
BV7‐3_ASSLTVTDTQY_BJ2‐3 | R1 | NO | ||||||||||||
BV20‐1_SASDSLNTEAF_BJ1‐1* | NO | |||||||||||||
BV20‐1_SASRQVADTQY_BJ2‐3 | R1 | NO |
The grey filling represents patients that express the indicated public TCR sequences. Some sequences were expressed by T cell clones (TCCs) that were tested for gluten reactivity. For these sequences, the gluten reactivity is indicated as NR; not reactive or R; reactive followed by the number of TCCs
The rightmost column denotes whether the public sequence have been O; observed or NO; not observed in a collection of previously defined public sequences of gluten‐specific CD4+ T cells
TCR‐α, TCR‐β, and paired TCR‐αβ sequences using identical V‐/J‐genes and identical CDR3 amino acid sequences found in the same cell subset of at least two patients were defined as public.